AI's most significant impact won't be on broad population health management, but as a diagnostic and decision-support assistant for physicians. By analyzing an individual patient's risks and co-morbidities, AI can empower doctors to make better, earlier diagnoses, addressing the core problem of physicians lacking time for deep patient analysis.

The most effective AI strategy focuses on 'micro workflows'—small, discrete tasks like summarizing patient data. By optimizing these countless small steps, AI can make decision-makers 'a hundred-fold more productive,' delivering massive cumulative value without relying on a single, high-risk autonomous solution.

The most significant opportunity for AI in healthcare lies not in optimizing existing software, but in automating 'net new' areas that once required human judgment. Functions like patient engagement, scheduling, and symptom triage are seeing explosive growth as AI steps into roles previously held only by staff.

Many pharma companies have breakthrough AI results in isolated functions, or "pockets of excellence." However, the ultimate competitive advantage will go to the company that first connects these disparate successes into a single, integrated, enterprise-wide AI capability, thereby creating compounded value across the organization.

The future business model for health tech will shift from subscriptions (SaaS) to outcomes. Vendors will be paid based on the tangible results they generate, such as cost savings or improved patient health, aligning incentives.

The high cost of bringing an AI model to market ($5-10M) limits adoption to elite hospitals. By reducing validation costs 100x (to $50-100k), innovators can lower prices, making AI accessible to all hospitals and creating a viable ROI.

An effective AI strategy in healthcare is not limited to consumer-facing assistants. A critical focus is building tools to augment the clinicians themselves. An AI 'assistant' for doctors to surface information and guide decisions scales expertise and improves care quality from the inside out.

Unlike the top-down, regulated rollout of EHRs, the rapid uptake of AI in healthcare is an organic, bottom-up movement. It's driven by frontline workers like pharmacists who face critical staffing shortages and need tools to manage overwhelming workloads, pulling technology in out of necessity.

A traditional IT investment ROI model misses the true value of AI in pharma. A proper methodology must account for operational efficiencies (e.g., time saved in clinical trials, where each day costs millions) and intangible benefits like improved data quality, competitive advantage, and institutional learning.